U.S. Patent Office denies Medtronic request in Endotach stent case

October 22, 2014 By Val Kennedy Leave a Comment

Boston Scientific must face trial in spat over stent patents

September 17, 2014 By Brad Perriello Leave a Comment

Johnson & Johnson logs win in Cordis-Medinol stent patent spat

August 12, 2014 By Brad Perriello Leave a Comment

J&J’s Conor MedSystems can’t slip $100M Biotronik lawsuit

May 20, 2014 By Brad Perriello Leave a Comment

Johnson & Johnson (NYSE:JNJ) subsidiary Conor MedSystems can’t slip a $100 million breach of contract lawsuit filed by former European distribution partner Biotronik, a New York state appeals court ruled last week.

Abbott claims win over Medinol in Dutch stent patent fight

May 13, 2014 By Brad Perriello Leave a Comment

ACC 2014 Roundup: Study shows long-term benefits for some CRT-D patients

March 31, 2014 By Brad Perriello Leave a Comment

Some patients with mild heart failure show significant, long-term benefits from cardiac-resynchronization therapy, according to the 7-year results from Boston Scientific‘s (NYSE:BSX) MADIT-CRT clinical trial presented at the American College of Cardiology’s annual meeting over the weekend.

Stent wars: Shrinkage concerns resurface in Medtronic/Boston Scientific DES trial

February 3, 2014 By Arezu Sarvestani Leave a Comment

Stent wars: Medtronic's Resolute DES bests Boston Scientific's Promus Element for stent deformation

Supreme Court denies stent pioneer Saffran in $600M patent case against J&J’s Cordis

January 28, 2014 By Brad Perriello Leave a Comment

Johnson & Johnson‘s (NYSE:JNJ) Cordis stent-making arm won the final round in a patent infringement battle with stent pioneer Dr. Bruce Saffran when the U.S. Supreme Court yesterday declined to hear Saffran’s appeal.

Boston Scientific wins FDA approval for Promus Premier stent

November 25, 2013 By Brad Perriello Leave a Comment

Boston Scientific (NYSE:BSX) said the FDA granted pre-market approval for its next-generation coronary stent, the Promus Premier.

Natick, Mass.-based Boston Scientific said it plans an immediate release for the Promus Premier, a drug-eluting stent made of a platinum-chromium alloy coated with everolimus.